Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Lifestyle-induced Hepatic Steatosis on Glucagon-stimulated Amino Acid Turnover

NCT04859322 is registered in ClinicalTrials.gov with Malte Palm Suppli, MD as lead sponsor.

NCT NCT04859322
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04859322 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Lifestyle-induced Hepatic Steatosis on Glucagon-stimulated Amino Acid Turnover
Lead sponsor
Malte Palm Suppli, MD
Phase
Not applicable
Overall status
Completed
Start date
February 8, 2021
Completion date
December 9, 2021
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glucagon resistance, non-alcoholic fatty liver disease